KRISTEN MUHOBERAC: Open Payments
NPI 1568109593 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 41 payments from 11 companies in 2025. Trend: 2023 $1,004 · 2024 $1,128 · 2025 $977
Food & beverage: $887Education: $90
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $323 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $226 |
| Sumitomo Pharma America, Inc. | 6 | $104 |
| Exeltis, USA Inc. | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Evofem Biosciences, Inc. | 5 | $46 |
| Organon LLC | 2 | $40 |
| MILLICENT US INC | 2 | $35 |
| PFIZER INC. | 1 | $24 |
| Hologic Sales and Service, LLC | 1 | $22 |
Products named: Veozah, BIJUVA, MYFEMBREE, SLYND, Mirena, Phexxi, NEXPLANON, ABRYSVO.
Industry payments across LA — which companies pay providers there.
